TY  - JOUR
AU  - Mantovani, Alessandro
PY  - 2018
TI  - The changing of natural history of nonalcoholic fatty liver disease (NAFLD): is advanced fibrosis the best predictor of long-term adverse outcomes?
JF  - AME Medical Journal; Vol 2, No 12 (December 2017): Ame Medical Journal
Y2  - 2018
KW  - 
N2  - Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease observed in clinical practice both in developed and in developing Countries (1). NAFLD affects approximately 25–35% among general adult population, 70–75% among patients with type 2 diabetes (T2DM) and up to 95% among those with obesity (1).
UR  - https://amj.amegroups.org/article/view/4219